498 related articles for article (PubMed ID: 19635888)
1. Persistent eosinophilia and Strongyloides infection in Montagnard refugees after presumptive albendazole therapy.
Goswami ND; Shah JJ; Corey GR; Stout JE
Am J Trop Med Hyg; 2009 Aug; 81(2):302-4. PubMed ID: 19635888
[TBL] [Abstract][Full Text] [Related]
2. Utility of serological follow-up of chronic strongyloidiasis after anthelminthic chemotherapy.
Page WA; Dempsey K; McCarthy JS
Trans R Soc Trop Med Hyg; 2006 Nov; 100(11):1056-62. PubMed ID: 16551471
[TBL] [Abstract][Full Text] [Related]
3. Parasite-specific IgG response and peripheral blood eosinophil count following albendazole treatment for presumed chronic strongyloidiasis.
Karunajeewa H; Kelly H; Leslie D; Leydon J; Saykao P; Biggs BA
J Travel Med; 2006; 13(2):84-91. PubMed ID: 16553594
[TBL] [Abstract][Full Text] [Related]
4. [An overview of Strongyloides stercoralis and its infections].
Ardiç N
Mikrobiyol Bul; 2009 Jan; 43(1):169-77. PubMed ID: 19334396
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of strongyloides in Northern Thailand and treatment with ivermectin vs albendazole.
Nontasut P; Muennoo C; Sa-nguankiat S; Fongsri S; Vichit A
Southeast Asian J Trop Med Public Health; 2005 Mar; 36(2):442-4. PubMed ID: 15916052
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the impact of overseas pre-departure treatment for infection with intestinal parasites among Montagnard refugees migrating from Cambodia to North Carolina.
Shah JJ; Maloney SA; Liu Y; Flagg EW; Johnston SP; Young SA; Weston R; Merritt S; Wilkins PP; Keane V; Calderon J; Sharp DJ; Causer L; Maguire JH; Cetron MS
Am J Trop Med Hyg; 2008 May; 78(5):754-9. PubMed ID: 18458310
[TBL] [Abstract][Full Text] [Related]
7. Strongyloides stercoralis, the hidden worm. Epidemiological and clinical characteristics of 70 cases diagnosed in the North Metropolitan Area of Barcelona, Spain, 2003-2012.
Valerio L; Roure S; Fernández-Rivas G; Basile L; Martínez-Cuevas O; Ballesteros ÁL; Ramos X; Sabrià M;
Trans R Soc Trop Med Hyg; 2013 Aug; 107(8):465-70. PubMed ID: 23783760
[TBL] [Abstract][Full Text] [Related]
8. Disseminated strongyloidiasis successfully treated with extended duration ivermectin combined with albendazole: a case report of intractable strongyloidiasis.
Pornsuriyasak P; Niticharoenpong K; Sakapibunnan A
Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):531-4. PubMed ID: 15689061
[TBL] [Abstract][Full Text] [Related]
9. Manifestations, diagnosis, and treatment of Strongyloides stercoralis infection.
Segarra-Newnham M
Ann Pharmacother; 2007 Dec; 41(12):1992-2001. PubMed ID: 17940124
[TBL] [Abstract][Full Text] [Related]
10. Management of chronic strongyloidiasis in immigrants and refugees: is serologic testing useful?
Biggs BA; Caruana S; Mihrshahi S; Jolley D; Leydon J; Chea L; Nuon S
Am J Trop Med Hyg; 2009 May; 80(5):788-91. PubMed ID: 19407125
[TBL] [Abstract][Full Text] [Related]
11. Case Report: Challenges for the Diagnosis and Treatment of Strongyloides stercoralis in Chronic Obstructive Pulmonary Disease Patients.
Ashiri A; Rafiei A; Beiromvand M; Khanzadeh A; Alghasi A
Am J Trop Med Hyg; 2021 Nov; 106(2):695-699. PubMed ID: 34844210
[TBL] [Abstract][Full Text] [Related]
12. The cost-effectiveness of ivermectin vs. albendazole in the presumptive treatment of strongyloidiasis in immigrants to the United States.
Muennig P; Pallin D; Challah C; Khan K
Epidemiol Infect; 2004 Dec; 132(6):1055-63. PubMed ID: 15635962
[TBL] [Abstract][Full Text] [Related]
13. [Recurrent strongyloidiasis as an indicator of HTLV-1 infection].
Richter J; Schwarz U; Duwe S; Ellerbrok H; Poggensee G; Pauli G
Dtsch Med Wochenschr; 2005 Apr; 130(16):1007-10. PubMed ID: 15830313
[TBL] [Abstract][Full Text] [Related]
14. Hyperinfection strongyloidiasis in a liver transplant recipient treated with parenteral ivermectin.
Lichtenberger P; Rosa-Cunha I; Morris M; Nishida S; Akpinar E; Gaitan J; Tzakis A; Doblecki-Lewis S
Transpl Infect Dis; 2009 Apr; 11(2):137-42. PubMed ID: 19144097
[TBL] [Abstract][Full Text] [Related]
15. A case of Strongyloides hyperinfection syndrome in the setting of persistent eosinophilia but negative serology.
Osiro S; Hamula C; Glaser A; Rana M; Dunn D
Diagn Microbiol Infect Dis; 2017 Jun; 88(2):168-170. PubMed ID: 28377165
[TBL] [Abstract][Full Text] [Related]
16. Mazzotti reaction after presumptive treatment for schistosomiasis and strongyloidiasis in a Liberian refugee.
Olson BG; Domachowske JB
Pediatr Infect Dis J; 2006 May; 25(5):466-8. PubMed ID: 16645520
[TBL] [Abstract][Full Text] [Related]
17. Strongyloides as a cause of fever of unknown origin.
Neumann I; Ritter R; Mounsey A
J Am Board Fam Med; 2012; 25(3):390-3. PubMed ID: 22570402
[TBL] [Abstract][Full Text] [Related]
18. Strongyloidiasis and other intestinal nematode infections.
Liu LX; Weller PF
Infect Dis Clin North Am; 1993 Sep; 7(3):655-82. PubMed ID: 8254165
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of a single-dose veterinary preparation of ivermectin versus 7-day high-dose albendazole for chronic strongyloidiasis.
Suputtamongkol Y; Kungpanichkul N; Silpasakorn S; Beeching NJ
Int J Antimicrob Agents; 2008 Jan; 31(1):46-9. PubMed ID: 18023151
[TBL] [Abstract][Full Text] [Related]
20. Comparative studies on the efficacy of three anthelminthics on treatment of human strongyloidiasis in Okinawa, Japan.
Toma H; Sato Y; Shiroma Y; Kobayashi J; Shimabukuro I; Takara M
Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):147-51. PubMed ID: 11023084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
